Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2014, Article ID 901315, 16 pages
http://dx.doi.org/10.1155/2014/901315
Research Article

Toona sinensis Inhibits LPS-Induced Inflammation and Migration in Vascular Smooth Muscle Cells via Suppression of Reactive Oxygen Species and NF-B Signaling Pathway

1Institute of Nutrition, China Medical University, Taichung, Taiwan
2Department of Health and Nutrition Biotechnology, Asia University, Taichung, Taiwan
3Department of Cosmeceutics, College of Pharmacy, China Medical University, Taichung, Taiwan
4Institute of Biochemistry and Biotechnology, Chung Shan Medical University, Taichung, Taiwan
5School of Pharmacy, College of Pharmacy, China Medical University, Taichung, Taiwan
6Department of Food Science and Technology, Ta-Jen University, Ping-Tung County, Taiwan
7Department of Medico Pharmaceutical Science, Nihon Pharmaceutical University, Komuro, Inamachi, Kita-Adachigun,Saitama, Japan

Received 22 October 2013; Revised 15 January 2014; Accepted 23 January 2014; Published 4 March 2014

Academic Editor: Guillermo Zalba

Copyright © 2014 Hsin-Ling Yang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F.-Y. Lin, Y.-H. Chen, J.-S. Tasi et al., “Endotoxin induces toll-like receptor 4 expression in vascular smooth muscle cells via NADPH oxidase activation and mitogen-activated protein kinase signaling pathways,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 12, pp. 2630–2637, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. R. R. S. Packard and P. Libby, “Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction,” Clinical Chemistry, vol. 54, no. 1, pp. 24–38, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. S.-K. Heo, H.-J. Yun, E.-K. Noh, W.-H. Park, and S.-D. Park, “LPS induces inflammatory responses in human aortic vascular smooth muscle cells via Toll-like receptor 4 expression and nitric oxide production,” Immunology Letters, vol. 120, no. 1-2, pp. 57–64, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. J. K. Kundu and Y.-J. Surh, “Breaking the relay in deregulated cellular signal transduction as a rationale for chemoprevention with anti-inflammatory phytochemicals,” Mutation Research, vol. 591, no. 1-2, pp. 123–146, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. R. de Martin, M. Hoeth, R. Hofer-Warbinek, and J. A. Schmid, “The transcription factor NF-kappa B and the regulation of vascular cell function,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 20, no. 11, pp. E83–E88, 2000. View at Google Scholar · View at Scopus
  6. M. Braun, P. Pietsch, K. Schrör, G. Baumann, and S. B. Felix, “Cellular adhesion molecules on vascular smooth muscle cells,” Cardiovascular Research, vol. 41, no. 2, pp. 395–401, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Libby, P. M. Ridker, and A. Maseri, “Inflammation and atherosclerosis,” Circulation, vol. 105, no. 9, pp. 1135–1143, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. A. C. Newby, “Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates,” Cardiovascular Research, vol. 69, no. 3, pp. 614–624, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. A. C. Newby and A. B. Zaltsman, “Molecular mechanisms in intimal hyperplasia,” Journal of Pathology, vol. 190, no. 3, pp. 300–309, 2000. View at Google Scholar
  10. H. Li, H. Xu, and B. Sun, “Lipopolysaccharide regulates MMP-9 expression through TLR4/NF-kappaB signaling in human arterial smooth muscle cells,” Molecular Medicine Reports, vol. 6, no. 4, pp. 774–778, 2012. View at Publisher · View at Google Scholar
  11. R. E. Clempus and K. K. Griendling, “Reactive oxygen species signaling in vascular smooth muscle cells,” Cardiovascular Research, vol. 71, no. 2, pp. 216–225, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. H.-M. Chen, Y.-C. Wu, Y.-C. Chia et al., “Gallic acid, a major component of Toona sinensis leaf extracts, contains a ROS-mediated anti-cancer activity in human prostate cancer cells,” Cancer Letters, vol. 286, no. 2, pp. 161–171, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. S. F. Louis and P. Zahradka, “Vascular smooth muscle cell motility: from migration to invasion,” Experimental and Clinical Cardiology, vol. 15, no. 4, pp. e75–e85, 2010. View at Google Scholar · View at Scopus
  14. Y.-C. Hseu, S.-C. Chen, W.-H. Lin et al., “Toona sinensis (leaf extracts) inhibit vascular endothelial growth factor (VEGF)-induced angiogenesis in vascular endothelial cells,” Journal of Ethnopharmacology, vol. 134, no. 1, pp. 111–121, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Y. Hsiang, Y. C. Hseu, Y. C. Chang, K. J. Kumar, T. Y. Ho, and H. L. Yang, “Toona sinensis and its major bioactive compound gallic acid inhibit LPS-induced inflammation in nuclear factor-kappaB transgenic mice as evaluated by in vivo bioluminescence imaging,” Food Chemistry, vol. 136, no. 2, pp. 426–434, 2013. View at Publisher · View at Google Scholar
  16. P. J. Huang, Y. C. Hseu, M. S. Lee et al., “In vitro and in vivo activity of gallic acid and Toona sinensis leaf extracts against HL-60 human premyelocytic leukemia,” Food and Chemical Toxicology, vol. 50, no. 10, pp. 3489–3497, 2012. View at Publisher · View at Google Scholar
  17. S. L. Poon, S.-F. Leu, H.-K. Hsu, M.-Y. Liu, and B.-M. Huang, “Regulatory mechanism of Toona sinensis on mouse leydig cell steroidogenesis,” Life Sciences, vol. 76, no. 13, pp. 1473–1487, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. B.-C. Yu, W.-J. Yu, C.-Y. Huang et al., “Toona sinensis leaf aqueous extract improves the functions of sperm and testes via regulating testicular proteins in rats under oxidative stress,” Evidence Based Complementary and Alternative Medicine, vol. 2012, Article ID 681328, 10 pages, 2012. View at Publisher · View at Google Scholar
  19. J.-W. Liao, C.-K. Hsu, M.-F. Wang, W.-M. Hsu, and Y.-C. Chan, “Beneficial effect of Toona sinensis Roemor on improving cognitive performance and brain degeneration in senescence-accelerated mice,” British Journal of Nutrition, vol. 96, no. 2, pp. 400–407, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. J.-W. Liao, J.-Y. Yeh, Y.-C. Lin, M.-M. Wei, and Y.-C. Chung, “Mutagenicity and safety evaluation of water extract of fermented Toona sinensis Roemor leaves,” Journal of Food Science, vol. 74, no. 1, pp. T7–T13, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. H.-C. Chang, W.-C. Hung, M.-S. Huang, and H.-K. Hsu, “Extract from the leaves of Toona sinensis Roemor exerts potent antiproliferative effect on human lung cancer cells,” The American Journal of Chinese Medicine, vol. 30, no. 2-3, pp. 307–314, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. Y.-C. Hseu, W.-H. Chang, C.-S. Chen et al., “Antioxidant activities of Toona Sinensis leaves extracts using different antioxidant models,” Food and Chemical Toxicology, vol. 46, no. 1, pp. 105–114, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. H.-L. Yang, W.-H. Chang, Y.-C. Chia et al., “Toona sinensis extracts induces apoptosis via reactive oxygen species in human premyelocytic leukemia cells,” Food and Chemical Toxicology, vol. 44, no. 12, pp. 1978–1988, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. H.-K. Hsu, Y.-C. Yang, J.-H. Hwang, and S.-J. Hong, “Effects of Toona sinensis leaf extract on lipolysis in differentiated 3T3-L1 adipocytes,” Kaohsiung Journal of Medical Sciences, vol. 19, no. 8, pp. 385–390, 2003. View at Google Scholar · View at Scopus
  25. Y. Shan, R. Zhao, W. Geng et al., “Protective effect of sulforaphane on human vascular endothelial cells against lipopolysaccharide-induced inflammatory damage,” Cardiovascular Toxicology, vol. 10, no. 2, pp. 139–145, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Qiang and K. Kinneer, “Chemoprotection by phenolic antioxidants. Inhibition of tumor necrosis factor α induction in macrophages,” The Journal of Biological Chemistry, vol. 277, no. 4, pp. 2477–2484, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. C. H. Selzman, S. A. Miller, and A. H. Harken, “Therapeutic implications of inflammation in atherosclerotic cardiovascular disease,” The Annals of Thoracic Surgery, vol. 71, no. 6, pp. 2066–2074, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. I. Darnton-Hill, C. Nishida, and W. P. T. James, “A life course approach to diet, nutrition and the prevention of chronic diseases,” Public Health Nutrition, vol. 7, no. 1A, pp. 101–121, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. Z. S. Galis, C. Johnson, D. Godin et al., “Targeted disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial remodeling,” Circulation Research, vol. 91, no. 9, pp. 852–859, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Kuzuya, S. Kanda, T. Sasaki et al., “Deficiency of gelatinase a suppresses smooth muscle cell invasion and development of experimental intimal hyperplasia,” Circulation, vol. 108, no. 11, pp. 1375–1381, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. F.-Y. Lin, Y.-H. Chen, Y.-L. Chen et al., “Ginkgo biloba extract inhibits endotoxin-induced human aortic smooth muscle cell proliferation via suppression of toll-like receptor 4 expression and NADPH oxidase activation,” Journal of Agricultural and Food Chemistry, vol. 55, no. 5, pp. 1977–1984, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. Y.-H. Son, Y.-T. Jeong, K.-A. Lee et al., “Roles of MAPK and NF-κB in interleukin-6 induction by lipopolysaccharide in vascular smooth muscle cells,” Journal of Cardiovascular Pharmacology, vol. 51, no. 1, pp. 71–77, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. W. T. Gerthoffer, “Mechanisms of vascular smooth muscle cell migration,” Circulation Research, vol. 100, no. 5, pp. 607–621, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Blankenberg, S. Barbaux, and L. Tiret, “Adhesion molecules and atherosclerosis,” Atherosclerosis, vol. 170, no. 2, pp. 191–203, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. S. Kim, Y. Ahn, M. H. Hong et al., “Rosuvastatin suppresses the inflammatory responses through inhibition of c-Jun N-terminal kinase and nuclear factor-κB in endothelial cells,” Journal of Cardiovascular Pharmacology, vol. 49, no. 6, pp. 376–383, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. L. L. Stoll, G. M. Denning, and N. L. Weintraub, “Potential role of endotoxin as a proinflammatory mediator of atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 12, pp. 2227–2236, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. R. P. Brandes and J. Kreuzer, “Vascular NADPH oxidases: molecular mechanisms of activation,” Cardiovascular Research, vol. 65, no. 1, pp. 16–27, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. P. A. Barry-Lane, C. Patterson, M. van der Merwe et al., “p47phox is required for atherosclerotic lesion progression in ApoE-/- mice,” The Journal of Clinical Investigation, vol. 108, no. 10, pp. 1513–1522, 2001. View at Publisher · View at Google Scholar · View at Scopus
  39. O. Inanami, J. L. Johnson, J. K. McAdara et al., “Activation of the leukocyte NADPH oxidase by phorbol ester requires the phosphorylation of p47PHOX on serine 303 or 304,” The Journal of Biological Chemistry, vol. 273, no. 16, pp. 9539–9543, 1998. View at Publisher · View at Google Scholar · View at Scopus
  40. A. W. Clowes, M. M. Clowes, Y. P. T. Au, M. A. Reidy, and D. Belin, “Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery,” Circulation Research, vol. 67, no. 1, pp. 61–67, 1990. View at Google Scholar · View at Scopus
  41. C. Monaco and E. Paleolog, “Nuclear factor κB: a potential therapeutic target in atherosclerosis and thrombosis,” Cardiovascular Research, vol. 61, no. 4, pp. 671–682, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. X. Zhang, R. Polavarapu, H. She, Z. Mao, and M. Yepes, “Tissue-type plasminogen activator and the low-density lipoprotein receptor-related protein mediate cerebral ischemia-induced nuclear factor-κB pathway activation,” The American Journal of Pathology, vol. 171, no. 4, pp. 1281–1290, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. Y. Son, Y.-K. Cheong, N.-H. Kim, H.-T. Chung, D. G. Kang, and H.-O. Pae, “Mitogen-activated protein kinases and reactive oxygen species: how can ROS activate MAPK pathways?” Journal of Signal Transduction, vol. 2011, Article ID 792639, 6 pages, 2011. View at Publisher · View at Google Scholar
  44. S.-J. Lin, I.-T. Lee, Y.-H. Chen et al., “Salvianolic acid B attenuates MMP-2 and MMP-9 expression in vivo in apolipoprotein-E-deficient mouse aorta and in vitro in LPS-treated human aortic smooth muscle cells,” Journal of Cellular Biochemistry, vol. 100, no. 2, pp. 372–384, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Cho, J. Graves, and M. A. Reidy, “Mitogen-activated protein kinases mediate matrix metalloproteinase-9 expression in vascular smooth muscle cells,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 20, no. 12, pp. 2527–2532, 2000. View at Google Scholar · View at Scopus
  46. E. K. O. Kruithof, “Regulation of plasminogen activator inhibitor type 1 gene expression by inflammatory mediators and statins,” Thrombosis and Haemostasis, vol. 100, no. 6, pp. 969–975, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. K. S. Kumar, V. Vijayan, S. Bhaskar, K. Krishnan, V. Shalini, and A. Helen, “Anti-inflammatory potential of an ethyl acetate fraction isolated from Justicia gendarussa roots through inhibition of iNOS and COX-2 expression via NF-κB pathway,” Cellular Immunology, vol. 272, no. 2, pp. 283–289, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. B. H. Kroes, A. J. J. van den Berg, H. C. Quarles van Ufford, H. van Dijk, and R. P. Labadie, “Anti-inflammatory activity of gallic acid,” Planta Medica, vol. 58, no. 6, pp. 499–504, 1992. View at Google Scholar · View at Scopus
  49. H.-L. Huang, C.-C. Lin, K.-C. G. Jeng et al., “Fresh green tea and gallic acid ameliorate oxidative stress in kainic acid-induced status epilepticus,” Journal of Agricultural and Food Chemistry, vol. 60, no. 9, pp. 2328–2336, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. K.-C. Choi, Y.-H. Lee, M. G. Jung et al., “Gallic acid suppresses lipopolysaccharide-induced nuclear factor-κB signaling by preventing RelA acetylation in A549 lung cancer cells,” Molecular Cancer Research, vol. 7, no. 12, pp. 2011–2021, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. A. Tachjian, V. Maria, and A. Jahangir, “Use of herbal products and potential interactions in patients with cardiovascular diseases,” Journal of the American College of Cardiology, vol. 55, no. 6, pp. 515–525, 2010. View at Publisher · View at Google Scholar · View at Scopus